POZ

RSS

Posts tagged with "ARV"

May 13
Preparing for Generics in the U.S.With patent expirations pending over the next four to five years for several Department of Health and Human Services (HHS)-preferred and -alternative ARVs,* attention to the potential for cost savings—along with the safety, efficacy and convenience of generic options to be made available in the U.S.—is now critical.

Preparing for Generics in the U.S.
With patent expirations pending over the next four to five years for several Department of Health and Human Services (HHS)-preferred and -alternative ARVs,* attention to the potential for cost savings—along with the safety, efficacy and convenience of generic options to be made available in the U.S.—is now critical.

Posted 1 week ago

1 note

Tim Horn, Generic HIV drugs, ARV, HHS, Department of Health and Human Services, cost savings, drug patents,

Apr 16
South Africa Begins Once-a-Day HIV Pill ImplementationThe country has begun implementing its plan to give about 180,000 people a fixed-dose combination antiretroviral (ARV) medication. It will be given to people newly diagnosed with HIV, as well as HIV-positive women who are pregnant or breast-feeding.

South Africa Begins Once-a-Day HIV Pill Implementation
The country has begun implementing its plan to give about 180,000 people a fixed-dose combination antiretroviral (ARV) medication. It will be given to people newly diagnosed with HIV, as well as HIV-positive women who are pregnant or breast-feeding.

Posted 1 month ago

6 notes

South Africa, treatment, HIV, ARV, Anti-retroviral, once-a-day, HIV pill,

Mar 5
ViiV Healthcare to Provide Low-cost Versions  HIV Medicine to Countries in Need ViiV Healthcare has granted a voluntary license to the Medicines Patent Pool (MPP) for pediatric formulations of the antiretroviral drug abacavir in 118 countries. To read more, Click here.

ViiV Healthcare to Provide Low-cost Versions  HIV Medicine to Countries in Need

ViiV Healthcare has granted a voluntary license to the Medicines Patent Pool (MPP) for pediatric formulations of the antiretroviral drug abacavir in 118 countries.

To read more, Click here.

Posted 2 months ago

3 notes

ViiV Healthcare, HIV, voluntary license, Medicines Patent Pool, MPP, low cost, ARV, antiretroviral, abacavir, medicines,

Feb 22
Uganda Study Adds to Growing Proof of Treatment as Prevention’s SuccessA study of serodiscordant heterosexual couples in Uganda has found that the HIV-positive partner never transmitted the virus to the other if he or she was taking antiretrovirals (ARVs). To read more, click here.

Uganda Study Adds to Growing Proof of Treatment as Prevention’s Success
A study of serodiscordant heterosexual couples in Uganda has found that the HIV-positive partner never transmitted the virus to the other if he or she was taking antiretrovirals (ARVs).

To read more, click here.

Posted 2 months ago

7 notes

Uganda, ARV, treatment as prevention, HIV, antiretrovirals, transmission,

Feb 16

South Africa to Make Active ARV Ingredients

South Africa will establish its first pharmaceutical plant to manufacture the main chemicals used in HIV drugs in an effort to lower the prices of antiretroviral (ARV) drugs, Reuters reports. The $211 million joint venture with Swiss chemical and biotechnology company Lonza Group will enable the country to produce Active Pharmaceutical Ingredients (API), components that account for about 75 percent of the finished drug dosage. The plant is a step toward producing ARVs in the country by 2016 to support the nearly 5.7 million people with HIV in South Africa. 

(Source: poz.com)

Posted 1 year ago

2 notes

South Africa, pharma, ARV, antiretrovirals, HIV, AIDS, Active Pharmaceutical Ingredients, API,

Jul 13

BREAKING NEWS: PrEP Reduces HIV Risk in Two African Studies


Two African studies of pre-exposure prophylaxis (PrEP) provide additional evidence that antiretroviral (ARV) drugs can be used to prevent HIV transmission, according to early results from both clinical trials, released ahead of their full presentations at the 6th International AIDS Society Conference of HIV Pathogenesis, Treatment and Prevention next week in Rome.

Posted 1 year ago

6 notes

Truvada, PreP, pre-exposure prophylaxsis, Africa, HIV, AIDS, ARV,

Jun 2
From the Newsfeed A Global Fund (GF) report identified 20 countries’ risks of running out of stocks of antiretroviral drugs (ARVs). The stock-outs result from poor forecasting, increasing patient enrollment and long procurement processes. The report also covered a host of global HIV/AIDS issues, including ARV theft, fund-raising and prevention of mother-to-child transmission. Click here for more.

From the Newsfeed

A Global Fund (GF) report identified 20 countries’ risks of running out of stocks of antiretroviral drugs (ARVs). The stock-outs result from poor forecasting, increasing patient enrollment and long procurement processes. The report also covered a host of global HIV/AIDS issues, including ARV theft, fund-raising and prevention of mother-to-child transmission. Click here for more.

Posted 1 year ago

3 notes

HIV, AIDS, Global Fund, ARV,

May 24

China Confronts AIDS

From the Newsfeed

The AIDS-related mortality rate in China has dropped 64 percent since the government began distributing free antiretroviral (ARV) drugs in 2002. About 63 percent of people who need ARVs are receiving them—up from virtually zero in 2002—and about 50 percent of the Chinese population has been tested for HIV. In comparison, the United States estimates that 80 percent of its 1.1 million residents who have the virus have been tested. Click here for more.

Posted 1 year ago

13 notes

HIV, AIDS, China, ARV, Lancet,

May 16
From the Blogs Same-Sex Couples Need Answer A new HIV prevention study supports what many researchers, activists and people living with the virus have believed for years—antiretroviral medications reduce HIV transmission in straight serodiscordant couples (where one person is HIV positive and one person is HIV negative) by 96 percent. This study provides hope for same-sex male couples, but it does not provide the scientific confirmation so much needed by men who have sex with men. I sincerely hope researchers and funders immediately begin to get those answers. Click here for more.

From the Blogs

Same-Sex Couples Need Answer

A new HIV prevention study supports what many researchers, activists and people living with the virus have believed for years—antiretroviral medications reduce HIV transmission in straight serodiscordant couples (where one person is HIV positive and one person is HIV negative) by 96 percent. This study provides hope for same-sex male couples, but it does not provide the scientific confirmation so much needed by men who have sex with men. I sincerely hope researchers and funders immediately begin to get those answers. Click here for more.

Posted 2 years ago

4 notes

HIV, ARV, serodiscordant, couples, sex,